India continues to be a leading supplier of vaccines, with 70 per cent of WHO's total vaccines being sourced from India. This ...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the drug development inputs & ...

Teva-engineered TEV-56278 is an anti-PD1-IL2 ATTENUKINE™ therapy in Phase 1 for the treatment of various forms of cancer, including melanoma Fosun Pharma-Teva collaboration agreement established with ...